OSCAR, Mouse, mAb 5B8
The monoclonal antibody 5B8 reacts with mouse osteoclast-associated receptor (OSCAR), which is a 265 amino acid type 1 transmembrane protein belonging to the leukocyte receptor complex protein family that play critical roles in the regulation of both innate and adaptive immune responses. In mice, OSCAR is a RANKL-inducible gene which- is expressed during the later stages of pre-osteoclast maturation and is shown to be a potent FcRγ-associated costimulatory receptor in vitro. OSCAR promotes osteoclastogenesis in vivo, and OSCAR binding to its collagen ligand led to signaling that- is involved in functional differentiation of leukocytes. In recent studies human OSCAR has been shown to play multiple roles in the immune system including activation and maturation of immune cells, prevention of apoptosis and enhancement of pro-inflammatory circuits. The latter by- inducing intracellular calcium release resulting in sustained IL-8 and chemokine expression leading to chemotaxis of Th2 effector and regulatory T-cells. In a- murine model using calvarias bone explants, the synovial fluid of osteoarthritis patients resulted in increased OSCAR mRNA expression suggesting that OSCAR might contribute to in the degenerative process. Moreover, in a recent study- OSCAR was found to be- induced in monocytes of RA patients, facilitating their differentiation into osteoclasts and bone resorption. The monoclonal antibody, 5B8, can be used for analysis of mouse OSCAR in flow-cytometry as well as functional studies for osteoclastogenesis.
Calculate your ELISA data easily
With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.
Latest Hycult Biotech news
- New Human Complement Pathway AssaysWe are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
- Navigating the pitfalls in complement analysisOur colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis
- NEW Human C3d ELISAWe are happy to introduce our new ELISA (cat.# HK3017) designed to detect human C3d. What sets this assay apart is its utilization of a distinctive neo-epitope capture antibody that selectively targets a specific C3d region of the alpha chain, which is not available in other C3 variants. This way it specifically distinguishes C3d from native C3… Read more: NEW Human C3d ELISA